Literature DB >> 34998611

Reactive chemistry for covalent probe and therapeutic development.

R Justin Grams1, Ku-Lung Hsu2.   

Abstract

Bioactive small molecules that form covalent bonds with a target protein are important tools for basic research and can be highly effective drugs. This review highlights reactive groups found in a collection of thiophilic and oxophilic drugs that mediate pharmacological activity through a covalent mechanism of action (MOA). We describe the application of advanced proteomic and bioanalytical methodologies for assessing selectivity of these covalent agents to guide and inspire the search for additional electrophiles suitable for covalent probe and therapeutic development. While the emphasis is on chemistry for modifying catalytic serine, threonine or cysteine residues, we devote a substantial fraction of the review to a collection of exploratory reactive groups of understudied residues on proteins.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  activity-based protein profiling; chemoproteomics; drug discovery; electrophile; targeted covalent inhibitor

Mesh:

Substances:

Year:  2022        PMID: 34998611      PMCID: PMC8840975          DOI: 10.1016/j.tips.2021.12.002

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  114 in total

1.  The influence of fluorine position on the properties of fluorobenzoxaboroles.

Authors:  Agnieszka Adamczyk-Woźniak; Małgorzata K Cabaj; Paulina M Dominiak; Patrycja Gajowiec; Błażej Gierczyk; Jacek Lipok; Łukasz Popenda; Grzegorz Schroeder; Ewelina Tomecka; Piotr Urbański; Dorota Wieczorek; Andrzej Sporzyński
Journal:  Bioorg Chem       Date:  2015-05-14       Impact factor: 5.275

2.  The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design.

Authors:  Jil Schrader; Fabian Henneberg; Ricardo A Mata; Kai Tittmann; Thomas R Schneider; Holger Stark; Gleb Bourenkov; Ashwin Chari
Journal:  Science       Date:  2016-08-05       Impact factor: 47.728

Review 3.  Enzyme inhibitor discovery by activity-based protein profiling.

Authors:  Micah J Niphakis; Benjamin F Cravatt
Journal:  Annu Rev Biochem       Date:  2014       Impact factor: 23.643

Review 4.  Progress with covalent small-molecule kinase inhibitors.

Authors:  Zheng Zhao; Philip E Bourne
Journal:  Drug Discov Today       Date:  2018-01-11       Impact factor: 7.851

5.  Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer.

Authors:  Jay B Fell; John P Fischer; Brian R Baer; James F Blake; Karyn Bouhana; David M Briere; Karin D Brown; Laurence E Burgess; Aaron C Burns; Michael R Burkard; Harrah Chiang; Mark J Chicarelli; Adam W Cook; John J Gaudino; Jill Hallin; Lauren Hanson; Dylan P Hartley; Erik J Hicken; Gary P Hingorani; Ronald J Hinklin; Macedonio J Mejia; Peter Olson; Jennifer N Otten; Susan P Rhodes; Martha E Rodriguez; Pavel Savechenkov; Darin J Smith; Niranjan Sudhakar; Francis X Sullivan; Tony P Tang; Guy P Vigers; Lance Wollenberg; James G Christensen; Matthew A Marx
Journal:  J Med Chem       Date:  2020-04-06       Impact factor: 7.446

6.  Ring Structure and Aromatic Substituent Effects on the pK a of the Benzoxaborole Pharmacophore.

Authors:  John W Tomsho; Arnab Pal; Dennis G Hall; Stephen J Benkovic
Journal:  ACS Med Chem Lett       Date:  2011-10-19       Impact factor: 4.345

7.  Discovery and optimization of piperidyl-1,2,3-triazole ureas as potent, selective, and in vivo-active inhibitors of α/β-hydrolase domain containing 6 (ABHD6).

Authors:  Ku-Lung Hsu; Katsunori Tsuboi; Jae Won Chang; Landon R Whitby; Anna E Speers; Holly Pugh; Benjamin F Cravatt
Journal:  J Med Chem       Date:  2013-10-23       Impact factor: 7.446

8.  SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization.

Authors:  Zilei Liu; Jie Li; Suhua Li; Gencheng Li; K Barry Sharpless; Peng Wu
Journal:  J Am Chem Soc       Date:  2018-02-16       Impact factor: 15.419

Review 9.  A global analysis of function and conservation of catalytic residues in enzymes.

Authors:  António J M Ribeiro; Jonathan D Tyzack; Neera Borkakoti; Gemma L Holliday; Janet M Thornton
Journal:  J Biol Chem       Date:  2019-12-03       Impact factor: 5.157

10.  Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.

Authors:  Jonathan Z Long; Weiwei Li; Lamont Booker; James J Burston; Steven G Kinsey; Joel E Schlosburg; Franciso J Pavón; Antonia M Serrano; Dana E Selley; Loren H Parsons; Aron H Lichtman; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2008-11-23       Impact factor: 15.040

View more
  1 in total

1.  A modification-centric assessment tool for the performance of chemoproteomic probes.

Authors:  Ji-Xiang He; Zheng-Cong Fei; Ling Fu; Cai-Ping Tian; Fu-Chu He; Hao Chi; Jing Yang
Journal:  Nat Chem Biol       Date:  2022-07-21       Impact factor: 16.174

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.